These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 1722373

  • 1. [Serum acute phase proteins for determining disease activity of ulcerative colitis and Crohn disease].
    Vucelić B, Milicić D, Krznarić Z, Korać B, Sentić M, Hadzić N, Stavljenić A, Cvorisćec D.
    Acta Med Austriaca; 1991; 18(4):100-5. PubMed ID: 1722373
    [Abstract] [Full Text] [Related]

  • 2. [Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].
    Vucelić B, Krznarić Z, Sentić M, Milicić D, Korać B, Cvorisćec D, Stavljenić A.
    Lijec Vjesn; 1990; 112(9-10):281-4. PubMed ID: 2093781
    [Abstract] [Full Text] [Related]

  • 3. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C, Backmerhoff F, Schumacher B, Niederau C.
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [Abstract] [Full Text] [Related]

  • 4. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 5. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ, Sáez-Royuela F, Yuguero del Moral L, Martín Lorente JL, Ojeda Giménez C.
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [Abstract] [Full Text] [Related]

  • 6. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K, Berger M, Niederau C, Frieling T.
    Hepatogastroenterology; 1999 Jan; 46(28):2309-14. PubMed ID: 10521988
    [Abstract] [Full Text] [Related]

  • 7. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy].
    Colombel JF, Mizon C, Chekkouri N, Balduyck M, Chaussade S, Becuwe C, Degand P, Mizon J, Cortot A.
    Gastroenterol Clin Biol; 1991 Jan; 15(4):301-5. PubMed ID: 2060740
    [Abstract] [Full Text] [Related]

  • 8. [Blood protein concentrations--are they parameters of disease activity in Crohn's disease?].
    Meryn S, Lochs H, Bettelheim P, Sertl K, Mulak K.
    Leber Magen Darm; 1985 Jul; 15(4):160-4. PubMed ID: 3877229
    [Abstract] [Full Text] [Related]

  • 9. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K, Niederau C, Frieling T.
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [Abstract] [Full Text] [Related]

  • 10. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
    Lindgren S, Florén CH, Lindhagen T, Starck M, Stewenius J, Nässberger L.
    Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationships between clinical data and histology of the large bowel in Crohn's disease and ulcerative colitis.
    Schmitz-Moormann P, Himmelmann GW, Brandes JW.
    Pathol Annu; 1985 Jun; 20 Pt 1():281-301. PubMed ID: 3991239
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Total parenteral nutrition modifies the acute phase response to Crohn's disease.
    Carlson GL, Gray P, Barber D, Shaffer JL, Mughal M, Irving MH.
    J R Coll Surg Edinb; 1994 Dec; 39(6):360-4. PubMed ID: 7532715
    [Abstract] [Full Text] [Related]

  • 17. [Application of chosen granulocyte markers in diagnostics of Leśniowski-Crohn's disease and ulcerative colitis--preliminary research].
    Fedak D, Pawlica D, Ciećko-Michalska I, Solnica B, Mach T.
    Przegl Lek; 2010 Dec; 67(2):114-8. PubMed ID: 20557011
    [Abstract] [Full Text] [Related]

  • 18. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C, Boirivant M, De Toma G, Cerci S, Subioli S, Scuro L, Ferrari P, Pallone F.
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [Abstract] [Full Text] [Related]

  • 19. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
    Rhodes JM, Potter BJ, Brown DJ, Jewell DP.
    Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
    [Abstract] [Full Text] [Related]

  • 20. [Acute phase proteins in acute pancreatitis].
    Dujmović F, Kulauzov M, Danicić B.
    Med Pregl; 1998 Jun; 51(9-10):395-9. PubMed ID: 9863327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.